Cat primary visual cortex has been used as an immunogen to produce monoclonal antibodies that detect subpopulations of neurons. When tested by immunofluorescence on tissue sections of areas 17 and 18, 2 of these antibodies, VC 1.1 and VC5.1, outlined a rare subpopulation of neurons located mainly in layer 4 but also in layers 5 and 6. Doublelabeling immunofluorescence experiments in area 17 revealed that all VCl .l -reactive cells were also VC5.1 -reactive and 83% of VC5.1 -reactive cells were VCl .l -reactive, suggesting that the antibodies were reacting with the same subpopulation of cells. Both antibodies labeled similar or identical subpopulations of cells in other areas of the cat CNS, including the superior colliculus, parts of hippocampus, cerebellar deep nuclei, and rostra1 spinal cord. Neither antibody labeled cell bodies in the lateral geniculate nucleus. In the retina, VC1.l labeled cell bodies and processes of some horizontal and amacrine cells, whereas VC5.1 labeled only ganglion cell axons. In the cerebellar cortex, the most prominent labeling of VC1.l was of Purkinje cells, whereas that of VC5.1 was of Lugaro cells. lmmunoblotting analyses of cat cortical homogenates demonstrated that VC1.l recognized a major polypeptide band of M, 95,000-105,000 and additional bands of M, 145,000 and M, 170,000. VC5.1 recognized bands of M, 97,000 and M, 150,000. Subcellular fractionation and extraction studies showed that the VC1.l antigens were integral membrane proteins preferentially located in a synaptosomal plasma membrane fraction. The VC5.1 antigens were preferentially located in a soluble cytoplasmic or extracellular fraction. The results indicate that antibodies VC1.l and VC5.1 recognize unique epitopes in the cat CNS and define a previously unrecognized subpopulation of cells in cat visual cortex.
Neuronal circuits of cerebral cortex contain a wide variety of cell classes arranged in characteristic radial and tangential patterns. Morphological distinctions between cortical cell classes have been made on the basis of Golgi staining (reviewed extensively in Peters and Jones, 1984) . Additional characterization of cortical circuitry has been made by correlating the electro-physiological response properties of single cells with their characteristic dendritic and axonal arborization patterns using intracellular dye or enzyme injections (Kelly and Van Essen, 1974; Gilbert and Wiesel, 1979; Lin et al., 1979; Somogyi et al., 1979) . A further step in the identification of structural elements of cortical circuits has been made using biochemical and immunological methods. High-affinity uptake of radiolabeled neurotransmitters followed by autoradiography has been used to reveal subpopulations of cells in cerebral cortex (Neal and Iversen, 1969; Hijkfelt and Ljungdal, 1972; Iversen and Bloom 1972; Baughman and Gilbert, 1981; reviewed in Streit, 1984) . Antisera against particular neuroactive substances or neurotransmitter-synthesizing enzymes have also been used to reveal the distribution ofdifferent transmitter-or neuropeptide-containing cell bodies and synaptic terminals in the cerebral cortex (Parnavelas and McDonald, 1983; Houser et al., 1983; Emson and Hunt, 1984) .
It is clear that the above methods alone cannot give a complete representation of the functional complexity in any given cortical area. It is likely that some aspects of this complexity are reflected in the heterogeneity of expression of cell-surface molecules. These molecules can now be detected by developing monoclonal antibodies against previously unknown or impure antigens and thus producing probes that can reveal cortical heterogeneity and define its molecular basis.
Monoclonal antibodies have already defined a variety of neural molecules, including some that are expressed on subclasses of cells or synapses. In the retina, for example, antibodies have been produced against each of the major subclasses of neuronal and glial cells (Bamstable, 1980; Bamstable et al., 1983 Bamstable et al., , 1985 . In other regions of the CNS, monoclonal antibodies have also been used to identify neuronal subsets (Hawkes et al., 1982; McKay and Hockfield, 1982; Stemberger et al., 1982; Wood et al., 1982; Kushner, 1984) . One conclusion from a number of immunological studies in both vertebrates and invertebrates has been that some of the antibodies recognize groups of cells that are related by function rather than by broader morphological or neurochemical criteria (Zipser and McKay, 198 1; Levitt, 1984; Bamstable, 1985; Akagawa and Bamstable, 1986) .
We have used material from cat area 17 as an immunogen to generate monoclonal antibodies that can identify new anatomical features and cell types in visual cortex. From the panel of antibodies that were obtained, 2, VC 1.1 and VU. 1, recognize a rare population of visual cortical neurons. In this study we describe the labeling patterns given by these antibodies in area 17 and other selected areas of the CNS, as well as some biochemical properties of the antigens recognized. Our findings describe a novel feature of cortical organization defined by the localization of antigens VCl. 1 and VC5.1. Part of this work has previously been presented in abstract form (Arimatsu et al., 1985) .
Materials and Methods
Antibody production.
Two female BALB/c mice were immunized with homogenates of cat area 17. The first immunization was intraperitoneal, with complete Freund's adjuvant; subsequent intraperitoneal injections used incomplete Freund's adjuvant, and the final injection was intravenous with the antigen in isotonic saline. One mouse received unfixed homogenate (20 mg wet weight) on days 0, 28, and 84. The other received homogenate (20 mg wet weight) fixed with 0.5% paraformaldehyde, as previously described (Fekeie and Bamstable, 19^83) on days 0, 28, 84, and 224. Four days after the final injection, the spleens were removed and approximately 2 x lo8 cells from each were fused with 2 x 10' P3-NSI/ 1 -Ag4-1 plasmacytoma cells, as described elsewhere (Kohler and Milstein. 1975: Bamstable. 1982) . Hvbrid cultures were selected in Hypoxanthine-Aminopterin-Thymi&ne (HAT) medium and culture supemafants of growing colonies were screened by indirect immunofluorescence. Selected hybridomas were recloned at least twice by limiting dilution. Immunoglobulin (Ig) subclass of secreted antibodies was determined with Ouchterlony analysis using subclass-specific antisera (Miles).
Screening
and histological characterization of antibodies.
Adult cats were deeply anesthetized with pentobarbital and intracardially perfused with PBS and then with 4% paraformaldehyde in PBS. One hour after the perfusion, the brains were removed, blocked, and postfixed in the same fixative for 5 hr at 4°C. The tissues were immersed in PBS containing 30% sucrose and embedded in O.C.T. compound (Miles). Cryostat sections were cut at 12 pm, mounted on gelatin-coated glass slides, and stored at -20°C until use. Indirect immunofluorescence labeling of sections was carried out as described previously (Bamstable, 1982) . To identify laminae of the visual cortex, selected sections were stained for cytochrome oxidase activity (Wong-Riley, 1979; Price, 1985) . The borders between cortical areas 17, 18, and 19 were determined by the cytoarchitectonic criteria of Otsuka and Hassler (1962) . Two-color immunojluorescence labeling with IgG and IgM. In order to examine the possible colocalization ofantigenic sites that were labeled with mouse monoclonal IgG or IgM, double immunofluorescence labeling experiments were performed. Sections were incubated sequentially with (1) a monoclonal antibody of IgG, (2) fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse Fc (Miles), (3) another mouse monoclonal antibody of IgM, and (4) rhodamine isothiocyanate (RITC)-conjugated goat anti-mouse IgM (Cappel; p-chain-specific). After washing in PBS, sections were coverslipped in a mounting medium containing 0.1 O/o paraphenylenediamine (Sigma) in PBS, pH 9.0, to retard fading of FITC fluorescence (Valnes and Brandtzaeg, 1985) , and viewed using a combination of filters for FITC and RITC. Control sections were incubated with normal culture medium containing 10% fetal calf serum instead of IgG (step 1) or instead of IgM (step 3). Subcellular fractionation of the cat cortical tissue was carried out essentially as described by Huttner et al. (1983) for rat cortex. The procedure is shown diagrammatically in Figure 1 . An adult cat was killed under deep anesthesia by pentobarbital. The brain was removed into ice-cold buffered sucrose (320 mM sucrose, 4 mM HEPES-NaOH, pH 7.4,0.05% NaN,). The cerebral cortex (14 gm wet weight) was dissected out from other portions of the brain and cut into small pieces. After removal of most of the white matter, the tissue was homogenized with 80 ml of buffered sucrose in a glass-Teflon homogenizer. The homogenate was centrifuged at 800 x g for 10 min. The pellet (Pl) was discarded. The supematant (Sl) was collected and centrifuged at 9200 x g for 15 min. The resulting supematant (S2) was centrifuged at 165,000 x g for 2 hr to yield a pellet (P3) and a cytosol fraction (C). The pellet (P2) obtained by centrifuging the Sl fraction was washed by suspension in 50 ml of buffered sucrose and centrifu- gation at 10,200 x g for 15 min. The washed pellet (P2') was resuspended in 15 ml of buffered sucrose. The synaptosome suspension was lysed by homogenization with 135 ml of H,O. The resulting P2' lysate (L) was adjusted to 8 mM HEPES, pH 7.4, incubated for 30 min and centrifuged at 25,000 x R for 20 min. The pellet (LPl) was removed and the-supematant (LSl) was centrifuged at 97,000 x g for 3 hr to vield a sunematant (LS2) and a nellet (LP2). The LP2 fraction was resuspended in 4 ml of 4O'mM sucrose byhomogenization. Three milliliters of the suspension was layered on a linear sucrose gradient made from 16 ml of 800 mM sucrose and 14 ml of 50 mM sucrose, centrifuged in a swinging bucket rotor at 65,000 x g for 5 hr, and the gradient was collected in 1.1 ml fractions through the bottom of the tube.
Zmmunoblotting. Aliquots of subcellular fractions of the cat cortex were applied to 7.5% SDS-polyacrylamide gels and electrophoresed using the buffer system of Laemmli (1970) in the presence of 2-mercaptoethanol. After electrophoresis, proteins were electrophoretically blotted onto nitrocellulose and labeled with antibodies, as described previously (Towbin et al., 1979; Fekete and Barnstable, 1983) . The labeled proteins were detected using HRP-conjugated anti-mouse IgG (H+L; Cappel). The apparent molecular weight of each stained band was determined by comparison with the migration of standard proteins and was derived from at least 3 separate experiments. Aliquots from the sucrose gradient-fractionated LP2 fraction were assayed on separate blots for the presence of VCl . 1 antigen and the synaptic vesicle protein ~38. The ~38 antigen was detected using monoclonal antibody 7.1 b (a sift from R. Jahn and P. Greenaard. Rockefeller University), whose specificity has already been documented (Jahn et al., 1985) . Direct comparison of the molecular weights of the VCl . 1 and VC5.1 determinants was facilitated by running aliquots of the same subcellular fractions on identical gels. Protein concentrations were determined by the method of Lowry et al. (1951) .
Solubilization of antigens. The LPl and P3 fractions from the cortical homogenate were used. Each fraction was washed by adding an excess of 10 mM Tris-HCl, pH 8.0, and centrifuging at 164,000 x g for 2 hr. The washed pellet was resuspended in the same hypotonic buffer by homogenization and frozen at -80°C (overnight) to ensure hypotonic lysis. Aliquots containing 1 mg protein were incubated at 4°C for 1 hr in 1 of the following solutions in a final volume of 1 ml: (1) 10 mM Tris-HCl, pH 8.0; (2) 1 M NaCl in 10 mM Tris-HCl, pH 8.0; (3) 3 M NaCl in 10 mM Tris-HCl, pH 8.0; (4) 10 mM Tris-HCl, pH 3.0; (5) 10 mMTris-HCl, pH 11.5; (6) 3% Triton X-100 in 10 mM Tris-HCl, pH 8.0: (7) 2% deoxvcholate in 10 mM Tris-HCl. DH 8.0. After incubation. the'samples were centrifuged at 164,000 x 'g for 2 hr. The resultant pellets and supematants were analyzed by immunoblotting, as described above.
Results
From the 2 fusions carried out, 1125 hybrid colonies were derived. These were screened by indirect immunofluorescence of fixed tissue sections of cat area 17. Two hundred and seventeen colonies ( 19%) showed positive immunoreactivity.
Most of these showed some selectivity in labeling, although few were as specific as the 2 described here. Antibody VC 1.1 was derived by immunization with unfixed homogenate, and antibody VCS. 1 by immunization with paraformaldehyde-fixed material. Ouchterlony double-diffusion against subclass-specific antisera defined VC1.l as an IgM and VC5.1 as an IgG,.
Immunojluorescence localization in area I7 Antibody VCI. I. Monoclonal antibody VC 1.1 outlined neuronal cell bodies and proximal portions of dendrites (Fig. 2) . The labeling was distributed around cell bodies in a discontinuous or fenestrated pattern. The neurons outlined by VCl. 1 were mainly in layer 4, but smaller numbers were also found in layers 5 and 6 (Fig. 3) . Some of the labeled cells were identified as multipolar nonpyramidal cells, but the exact class of the others could not be identified because of incomplete dendritic labeling. Cortical layers (indicated by numerals) were determined by the staining pattern for cytochrome oxidase activity originally described by WongRiley (1979) (see Fig. 4C ). Artifacts due to folding of the section are seen in layer 6 and white matter (W&Q.
In addition to outlining some neurons strongly, VC 1.1 showed further along the dendrites, the laminar distribution of VC5.1 a much less distinct labeling of neuropil. labeling in this area was the same as that of VC 1.1, with most Antibody VC.5.1. Monoclonal antibody VC5.1 also outlined labeled cells in layer 4 and a few in layers 5 and 6 (Fig. 4A) . subpopulations of neurons in area 17. Although labeling apSome of the VU. 1 -positive cells were identified as nonpyramipeared more continuous than with VC 1.1 and tended to extend da1 by their well-labeled dendritic arbors, which most closely 4 6 WM Figure 4 . A, Photomontage of immunofluorescence for VC5.1 in a frontal section of rostral area 17. Cortical layers (indicated by numerals) were determined by the staining pattern for cytochrome oxidase activity. B, Immunofluorescence photomicrograph for VC5.1 in area 18 in the same section as A. C', Cytochrome oxidase staining in a section adjacent to that shown in A and B. In area 17, layer 4 is distinctly identified by heavy staining for the enzyme, as described previously (Wong-Riley, 1979; Price; . Areas corresponding to A and B are shown by rectangles. Scale in A and B, 100 pm. Scale in C, 1 mm. Colocalization of VCI. I and VC5. I immunofluorescence. Because the labeling patterns given by VCl. 1 and VC5.1 were so similar in area 17, double-labeling experiments were performed to test whether the labeled cell populations were identical. Because VC 1.1 was an IgM and VCS. 1 was an IgG, , the antibodies could be distinguished from each other on the same sections using RITC-conjugated anti-mouse IgM for VC 1.1 and FITCconjugated anti-mouse Fc for VC5.1. Within area 17, the great majority of VC5.1 -immunoreactive neurons were also immunoreactive to VCl. 1 (Fig. 5 , A,@. Among 100 immunoreactive neurons counted in 1 section, 83 were labeled by both VCl . 1 and VC5.1. The remaining 17 neurons were labeled by VC5.1 but not by VCl. 1. Control sections incubated with' VCl. 1 but not VC5.1 showed no specific FITC fluorescence (see Fig. 5, C,D) . Similarly, sections incubated with VC5.1, but not VCl . 1, showed no specific RITC fluorescence (see Fig. 5, E,F) .
Localization of VCl.1 and VC5.1 immunoreactivity in other CNS regions
In addition to area 17, both antibodies labeled other regions of cat CNS. To further characterize the labeling patterns given by the 2 antibodies, selected regions were examined by indirect immunofluorescence.
In cortical area 18, VCl . 1 and VC5.1 labeled subpopulations of neurons within middle and deep layers (see Fig. 4B for VC5.1 labeling). In the superior colliculus, the immunofluorescence for both VCl. 1 and VC5.1 outlined subpopulations of neurons against a background of neuropil labeling that was detected in all layers in a nonuniform way. Double-labeling experiments showed that at least some neurons were labeled by both antibodies (data not shown). Neither antibody labeled cell bodies in the lateral geniculate nucleus. In the retina, VC 1.1 labeled structures within the inner and outer plexiform layers, and horizontal and amacrine bodies were also clearly outlined in the inner nuclear layer (Fig. 6A) . In contrast, VC5.1 did not label plexiform or nuclear layers but did label the optic nerve fiber layer (Fig. 6B ).
In the hippocampus, VC 1.1 and VC5.1 immunofluorescence outlined subpopulations of granule cells in the dentate gyrus and pyramidal cells in CA2-CA4 (data not shown). The labeling given by the 2 antibodies was very similar. Only very few CA1 pyramidal cells were outlined by either antibody. Some neuropil labeling for VC 1.1 and VC5.1 was also observed, although the intensity varied between layers. The neuropil labeling for these antibodies was strong in the hilus of the dentate gyrus, particularly near the granule cell layer.
In the cerebellar cortex, VCl . 1 gave punctate labeling in Purkinje cell bodies (Fig. 6C) , whereas VC5.1 outlined Lugaro cells (see Palay and Chan-Palay, 1973 Figure 8 . Top, VCl . 1 immunoreactivity in fractions after continuous sucrose density-gradient centrifirgation of fraction LP2. Aliquots (90 ~1) of alternate fractions (Fr.) were electrophoresed, blotted, and stained with VCl.l, as described in the text. Bottom, Immunoreactivity for ~38, a synaptic vesicle protein, in fractions after continuous sucrose density-gradient centrifugation of fraction LP2. Aliquots (75 ~1) were electrophoresed, blotted, and stained with monoclonal antibody 7.lb (a gift from Dr. R. Jahn, The Rockefeller University), as described in the text.
Purkinje cells corresponding to the terminal regions of basket cells (Fig. 60) . Occasionally, VCS.l-positive Golgi cells were observed (Fig. 6E ). Both VC1.l and VC5.1 showed intense labeling around many neurons in cerebellar deep nuclei (Fig. 6 , EG). In the rostra1 spinal cord, strong labeling was observed with VCl. 1 and VC5.1 around selected neuronal populations, including motor neurons of the ventral horn (Fig. 6, H,I ). In the gray matter, both antibodies showed a similar pattern of neuropil labeling. Strong immunofluorescence was observed in the substantia gelatinosa and areas around the central canal. In the white matter, these antibodies labeled structures between myelinated axons (see Fig. 6 , H,Z).
Subcellular distribution of VCl.1 and VC5.1 antigens The antigens detected by monoclonal antibodies VCl. 1 and VC5.1 were characterized by immunoblotting analysis on various subcellular fractions from cat cortex.
Antibody VCI. I. Antibody VC 1.1 recognized a major polypeptide band of&f, 95,000-105,000 and additional minor bands of M, 145,000 and M, 170,000 in the cortical homogenates (Fig.  7) . When these homogenates were fractionated by differential centrifugation, the polypeptide band of.M, 95,000-105,000 was the most enriched in the LPl fraction, a low-speed pellet of a crude synaptosomal lysate. Lower levels of immunoreactivity were found in the microsomal fraction (P3) and the LP2 fraction, a high-speed pellet of the synaptosomal lysate. The cytosol fraction (C) and a high-speed supematant of the lysate (LS2) had only a low level of immunoreactivity for this band. The minor polypeptide bands of higher molecular weight (M, 145,000 and M, 170,000) showed a different fractionation pattern and were localized mainly in the P3 and LP2 fractions.
Reactivities for all 3 polypeptide bands were detected with the LP2 fraction. Because this fraction is known to contain both synaptic membranes and vesicles, these components were separated using a continuous sucrose gradient of 50-800 mM. As shown at the top of Figure 8 , reactivity for all 3 bands was found in fractions 2-10, near the bottom of the gradient. Much lower levels of reactivity were found in the middle portions of the gradient (fractions 12-l 8). These fractions were enriched in synaptic vesicles, which were identified by labeling separate immunoblots of the same fractions for a synaptic vesicle-specific protein, ~38 (Jahn et al., 1985) (Fig. 8, bottom) . At the top of the gradient (fractions 24-28), reactivity was found in a number of low-molecular-weight bands. Since these were not present in the sample loaded on the gradient (lane LP2 in Fig. 7) , they probably represent proteolytic degradation products of sample handling and centrifugation. Similarly, a minor band of molecular weight higher than M, 170,000 was found in fractions 24-28 but was not found in the starting LP2 fraction. VC5.1 (Fig. 9) . Among the various subcellular fractions derived from the homogenate, the cytosol fraction (C)was most enriched in VC5.1 immunoreactivity, although some reactivity was also found in the microsomal fraction (P3) and the supernatants of synaptosomal lysate (LS 1 and LS2).
Solubilization of VCl. 1 antigens VCl.1 antigens of ikf, 95,000-105,000, M, 145,000, and M, 170,000 were localized in particulate fractions (LPl, LP2, and P3) but not in soluble fractions (C and IS2), which suggests that the antigens were membrane-associated. The nature of the association of these antigens in the LPl and P3 fractions was characterized by incubating each fraction in buffers of high ionic strength, low or high pH, or in the presence of detergent. As shown in Figure 10 , high ionic strength ( 1 M NaCl, Fig. 10 , lane 2; 3 M NaCl, lane 3) and low or high pH (pH 3, Fig. 10 , lane 4; pH 11.5, lane 5) caused no effective solubilization of these antigens. However, all 3 bands of VCl . 1 antigens in both fractions were solubilized very effectively with 2% deoxycholate (Fig. 10, lane 7 ) and less effectively with 3% Triton X-100 (lane 0
Discussion
We have used an immunological approach to define new structural features of cat CNS. In area 17, antibodies VC1.l and VC5.1 each labeled rare subpopulations of neurons, most of which were located in layer 4, with the remainder in layers 5 and 6. Two-color immunofluorescence labeling of tissue sections from area 17 showed that 83% of cells labeled with VC5.1 were also labeled with VCl . 1. The remaining cells were VC5.1 -pasitive/VCl . 1 -negative. Because VC 1.1 is an IgM and penetrates tissue less well than VC5.1, which is an IgG, it is likely that the figure of 83% for double-labeled cells is an underestimate and that the 2 antibodies were recognizing the same population. In spite of this close similarity in labeling patterns in area 17, the epitopes recognized by VCl . 1 and VC5.1 were clearly different. Evidence suggestive of this was the different quality and extent of labeling given by the 2 antibodies. VCl . 1 gave a punctate labeling around cell bodies and proximal portions of dendrites, whereas VC5.1 gave a more homogeneous labeling, which extended further out along the dendritic shafts. We cannot yet exclude the possibility that this difference was also related to the separate subclasses of the 2 antibodies. Clear variations in the staining patterns in retina and cerebellum, however, do suggest that different determinants were being recognized. More definitive evidence for the difference between the antigenic determinants was obtained from the biochemical studies. The 2 antibodies labeled separate molecular-weight bands on immunoblots of gels that were run at the same time, using the same fractions. VCl. 1 recognized a major band ofM, 95,000-105,000
and minor bands of M, 145,000 and M, 170,000. All 3 bands appeared to be integral membrane proteins since they were only extracted from the membrane by detergent and not by highionic-strength buffer or low or high pH. The molecular-weight range of the major band suggests that it may be glycosylated and thus a cell-surface molecule. This band was most prevalent in the synaptosomal plasma membrane fraction (LPl), whereas the other bands were more prevalent in the P3 and LP2 fractions. The relationship between the 3 bands and the significance of the different subeellular localization must await a more detailed characterization of the respective molecules. VC5.1 recognized 2 polypeptides, of M, 97,000 and M, 150,000. To detect these bands on the immunoblots it was necessary to load over twice as much protein as was necessary for VC 1.1. The 2 VCS. 1 -immunoreactive bands were preferentially localized in the soluble and microsomal fractions. Most of the microsomal antigen could be released into soluble compartments by hypotonic lysis and was thus probably material trapped within resealed membrane vesicles. Since VC5.1 labeling outlined cells rather than giving a uniform cytoplasmic labeling, the antigen is unlikely to be evenly distributed throughout the cytoplasm. It is possible that the antigen is loosely associated with the plasma membrane and is released upon homogenization. Alternatively, the VC5.1 determinant may be carried on an extracellular molecule that is soluble in isotonic buffers. Several such molecules have been described in other species (Delpech and Halavent, 198 1; Grumet et al., 1985; Kruse et al., 1985) . None of them, however, has the same biochemical characteristics as VC5.1.
The similarity in labeling patterns given by antibodies VC 1.1 and VC5.1 and the similarity of molecular weights on immunoblots is worth noting. The differences in tissue distribution and the clear-cut difference in subcellular distribution discussed above both eliminate the possibility that the 2 antibodies are recognizing the same epitope. The possibility that the 2 antibodies recognize separate forms of the same molecule is also unlikely, given the range of differences of the 2 determinants, although it cannot be entirely excluded at present.
In many CNS areas, the clearest labeling by both VC 1.1 and VC5.1 antibodies was around cell bodies and the proximal por-tions of dendrites, but the antibodies also gave a less distinct labeling in some neuropil areas away from the cell bodies. There are 2 possible explanations for the observed labeling patterns. One explanation of the neuropil immunoreactivity is that the antigens are expressed on postsynaptic cells and their distal dendrites. For example, the small circles of label in Figure 6G probably represent dendrites cut in cross section. The more diffuse neuropil labeling might represent the finer extensions of dendritic processes that cannot be individually resolved with the immunofluorescence methods used. The clearest example of this is the labeling of retina given by VCl.l, in which horizontal and amacrine cell bodies and their processes in the inner and outer plexiform layers were labeled.
The other explanation is that the labeling represents the presynaptic elements of a particular synaptic input, the bulk of which is concentrated around the cell bodies, but some of which is located on more distal portions of dendrites. A number of inhibitory neurons are known to make Gray's type II symmetrical contacts, which are concentrated in the vicinity of the cell body and proximal dendrites of visual cortical cells (LeVay, 1973; Houser et al., 1984) . This would suggest that the labeled presynaptic elements in area 17 are part of an inhibitory circuit. It is not yet clear whether such an explanation is consistent with the labeling patterns of either antibody in the other regions of CNS.
Three other antibodies that also outline highly restricted subpopulations of neurons in the mammalian CNS have been described. One of these, Tor 23, generated against Torpedo electric organ synaptosomes, outlined a small subpopulation of neurons in rat cerebral cortex in a manner similar to that of VC 1.1 and VC5.1 (Kushner, 1984) . The molecule recognized by this antibody, however, migrated as a single band of M, 180,000 in SDS-polyacrylamide gels (Kushner and Stephenson, 1983; Kushner, 1984 ). An antiserum against an extracellular matrix glycoprotein called hyaluronectin outlined approximately 10% of the neurons in a number of rat brain regions, including the cerebral cortex . Hyaluronectin from human brain was composed of 2 forms with molecular weights of 66,000 and of 100,000, as determined by gel-permeation chromatography (Delpech, 1982 ). An antibody raised against cat spinal cord, Cat30 1, preferentially labeled subpopulations of neurons in area 17 of the cat and monkey, as well as subpopulations in a variety of other CNS regions. Cat30 1 -positive cells in visual cortex and lateral geniculate nucleus (LGN) corresponded to morphologically distinct types of neurons that shared the common feature of belonging to the Y-cell pathway (Hendry et al., 1984a ). The Cat301 antibody shows several differences from and similarities to antibodies VCl. 1 and VC5.1 at the cellular level. All 3 antibodies label structures at the surface of neuronal cell bodies and proximal dendrites, but not axons. Both VCl . 1 and Cat30 1 have an irregular lattice-like distribution of binding sites across cell surfaces, which extends from the surface of the stained cells into surrounding neuropil.
Cat30 1 immunoreactivity in different regions of the cat visual system clearly differs from that of either VCl.l or VC5.1. In area 17, VCl. 1 and VC5.1 immunoreactivity is restricted to nonpyramidal neurons in layers 4, 5, and 6, whereas Cat301 stains subsets of both pyramidal and nonpyramidal neurons in layers 2, 3, 4A, 5, and 6 (MacAvoy et al., 1985) . It is possible that a subset of cortical nonpyramidal neurons may share all 3 determinants, although double-labeling studies would be needed to confirm this. In the lateral geniculate nucleus, Cat30 1 staining was strong, whereas VC 1.1 and VC5.1 immunoreactivity was not detectable . Finally, in the retina, VCl. 1 and VC5.1 immunoreactivity is strong (although each labels different structures), whereas Cat30 1 immunoreactivity has not been detected. In other regions of the CNS, VCl . 1 and VC5.1 show interesting similarities to and differences from Cat301. In the cerebellum, VC5.1 labeled the Lugaro cells, a rare neuronal cell population; basket cell terminals around Purkinje cells; and an occasional Golgi cell. Cat301 labeled only the Lugaro cells. All 3 antibodies showed similar intense labeling around subsets of motor neurons in the ventral horn of the spinal cord.
The subsets of neurons immunoreactive to antibodies VCl. 1 and VC5.1 seem not to correspond to any subpopulations of cortical neurons so far identified by conventional anatomical methods or by immunocytochemical localization of neuroactive substances. On the basis of the dendritic staining patterns, these neurons are clearly nonpyramidal and possess features of multipolar and bitufted (see Fig. 4B ) varieties of intemeurons previously described using other methods (Lund et al., 1979; Somogyi, 1979; Fairen and Valverde, 1980; Peters and Regidor, 198 1; Meyer, 1983) . The lack of clear axonal labeling given by either antibody has not allowed us to use axonal morphology as a further criterion for identifying the morphological class labeled. It is known that some nonpyramidal neurons in all layers of mammalian visual cortex contain GABA and its synthetic enzyme glutamic acid decarboxylase (Ribak, 1978; Hendrickson et al., 198 1; Freund et al., 1983; Hendry et al., 1984b; Houser et al., 1984; Otterson and Storm-Mathisen, 1984; Somogyi et al., 1984; Lin et al., 1986) . The morphology and distribution of subpopulations of cortical neurons have also been detected by antisera against particular neuropeptides (Hendry et al., 1984b, c; Demeulemeester et al., 1985; Lin et al., 1986) . Most of these subpopulations occur throughout all cortical layers but differ in relative frequencies within various layers. For example, cholecystokinin-immunoreactive cells occur chiefly in layers 1 and 2 + 3, whereas somatostatin-immunoreactive cells occur mainly in layers 2 + 3 and 6 (Demeulemeester et al., 1985) . Colocalization of GABA and several neuropeptides has defined smaller subpopulations of neurons (Hendry et al., 1984b; Somogyi et al., 1984) but none of these has the same distribution as that of VCl. 1-or VC5.1 -labeled cells. Preliminary results suggest that most, if not all, of the layer 4, 5, and 6 cells outlined by VCl. 1 also contain GABA (Naegele et al., 1986) . It seems likely that VC 1.1 and VC5.1 mark a subpopulation, or subpopulations, of GABAergic cells that has not been previously defined by GABA-neuropeptide phenotype. In summary, we have produced immunological reagents that, in cat visual cortex, define molecules restricted to a previously unrecognized subclass of neurons. By using these reagents in combination with other forms of analysis, it will be possible to determine whether the molecules we have defined are part of a particular functional circuit and whether they play any role in the interactions necessary for setting up such circuits.
